Tumor regression induced by YM155, a novel, survivin suppressant, in human diffuse large B-cell lymphoma models

被引：0

作者：

Kaneko, Naoki ^{[1
]}

Kita, Aya ^{[1
]}

Nakahara, Takahito ^{[1
]}

Nakata, Mari ^{[1
]}

Koutoku, Hiroshi ^{[1
]}

Sasamata, Masao ^{[1
]}

机构：

[1] Astellas Pharma Inc, Appl Pharmacol Res Labs, Tsukuba, Ibaraki 3058585, Japan

来源：

JOURNAL OF PHARMACOLOGICAL SCIENCES | 2010年 / 112卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：260P / 260P

页数：1

共 50 条

[21] MEDI 312-Discovery of YM155, a novel survivin suppressant for the treatment of cancer
Kinoyama, Isao
Matsuhisa, Akira
Nakahara, Takahito
Takeuchi, Masahiro
Shirasuna, Kenna
Minematsu, Tsuyoshi
Asai, Norio
Matsumoto, Shunichiro
Kawaguchi, Kenichi
Kazami, Junichi
Toyoshima, Akira
Kita, Aya
Tominaga, Fumiko
Okada, Minoru
Ohta, Mitsuaki
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[22] Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
Satoh, Taroh
Okamoto, Isamu
Miyazaki, Masaki
Morinaga, Ryotaroh
Tsuya, Asuka
Hasegawa, Yoshikazu
Terashima, Masaaki
Ueda, Shinya
Fukuoka, Masahiro
Ariyoshi, Yutaka
Saito, Toshikazu
Masuda, Noriyuki
Watanabe, Hirokazu
Taguchi, Tetsuo
Kakihara, Toru
Aoyama, Yumiko
Hashimoto, Yohko
Nakagawa, Kazuhiko
CLINICAL CANCER RESEARCH, 2009, 15 (11) : 3872 - 3880
[23] CHARACTERIZATION OF THE CARRIER-MEDIATED HEPATIC UPTAKE OF YM155, A NOVEL SURVIVIN SUPPRESSANT, INTO CRYOPRESERVED HUMAN HEPATOCYTES
Iwai, Megumi
Minematsu, Tsuyoshi
Usui, Takashi
Kamimura, Hidetaka
DRUG METABOLISM REVIEWS, 2007, 39 : 67 - 67
[24] YM155, a novel survivin suppressant, demonstrates activity in subjects with stage III or IV melanoma
Gonzalez, R.
Samlowski, W.
Cranmer, L.
Catlett, J.
Whitman, E.
Lawson, D.
Lewis, K.
Drake, T.
Bartels, P.
Buell, D.
Keating, A.
Kirkwood, J.
ANNALS OF ONCOLOGY, 2007, 18 : 40 - 40
[25] YM155, a novel survivin suppressant, demonstrates anti-tumor activity in patients with advanced solid tumors and non-Hodgkin's lymphoma
Tolcher, AW
Antonia, S
Lewis, LD
Mita, A
Mahany, JJ
Reddy, NJ
Till, E
Buell, D
Keating, AT
ANNALS OF ONCOLOGY, 2006, 17 : 23 - 23
[26] Radiosynthesis, biodistribution and imaging of [11C]YM155, a novel survivin suppressant, in a human prostate tumor-xenograft mouse model
Murakami, Yoshihiro
Matsuya, Takahiro
Kita, Aya
Yamanaka, Kentaro
Noda, Akihiro
Mitsuoka, Keisuke
Nakahara, Takahito
Miyoshi, Sosuke
Nishimura, Shintaro
NUCLEAR MEDICINE AND BIOLOGY, 2013, 40 (02) : 221 - 226
[27] YM155, a Novel Small-Molecule Survivin Suppressant, Combined With Radiation Therapy in Prostate Cancer Cell Lines
Thoms, J.
Aoki, S.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S648 - S648
[28] Involvement of Multidrug Resistance 1 (MDR1) for the Pharmacokinetics of YM155, a Novel Survivin Suppressant
Iwai, Megumi
Minematsu, Tsuyoshi
Li, Qun
Iwatsubo, Takafumi
Usui, Takashi
DRUG METABOLISM REVIEWS, 2010, 42 : 288 - 289
[29] METABOLISM OF YM155 MONOBROMIDE, A NOVEL SURVIVIN SUPPRESSANT: IN VITRO SPECIES COMPARISON AND IDENTIFICATION OF METABOLITES IN RATS
Sohda, Kin-ya
Suzuki, Katsuhiro
Nakamura, Eiji
Minematsu, Tsuyoshi
Hashimoto, Tadashi
Imai, Harumitsu
Usui, Takashi
Kawamura, Akio
Kamimura, Hidetaka
DRUG METABOLISM REVIEWS, 2007, 39 : 253 - 254
[30] The Survivin Suppressant YM155 Potentiates Chemosensitivity to Gemcitabine in the Human Pancreatic Cancer Cell Line MiaPaCa-2
Yoon, Dok Hyun
Shin, Jae-Sik
Jin, Dong-Hoon
Hong, Seung-Woo
Jung, Kyung A.
Kim, Seung-Mi
Hong, Yong Sang
Kim, Kyu-Pyo
Lee, Jae-Lyun
Suh, Cheolwon
Lee, Jung Shin
Kim, Tae Won
ANTICANCER RESEARCH, 2012, 32 (05) : 1681 - 1688

← 1 2 3 4 5 →